Sustained-immunostimulatory nanocellulose scaffold to enhance vaccine efficacy

J Biomed Mater Res A. 2020 May;108(5):1159-1170. doi: 10.1002/jbm.a.36890. Epub 2020 Feb 4.

Abstract

An implantable scaffold-based vaccination system is a promising platform to generate robust immune responses by modulating the immune system. However, establishment of an effective vaccine using a biodegradable, cell-infiltrative scaffold remain challenging. Here we demonstrate a biodegradable, nanocellulose-based immune scaffold capable of sustainably activating immune cells to elicit cellular immunity. Cell-infiltrative nanocellulose hydrogels were used as a delivery carrier and cellular scaffold microenvironment. Nanofibrous hydrogels allowed for high cell infiltration and delivery of antigen-loaded nanocellulose while cells degraded the hydrogel matrix. Importantly, antigen-loaded nanocellulose hydrogels exhibited sustained activation of macrophages in vitro compared to free antigen and collagen scaffold. Histological observation revealed infiltration of macrophages and dendritic cells into the nanocellulose scaffold subcutaneously implanted in mice. In vivo fluorescence imaging indicated that the implanted scaffold released antigens at a zero-order release profile without burst diffusion. Antigen-loaded nanocellulose hydrogels increased interferon-γ-producing cells compared to free antigen injection, suggesting the enhancement of cellular immunity. Thus, nanocellulose immune scaffold may serve as a sustained-immunostimulatory vaccine platform by providing favorable microenvironments for immune cells thus enhancing vaccine efficacy.

Keywords: drug delivery; hydrogel; immune scaffold; nanocellulose; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / chemistry*
  • Adjuvants, Immunologic / pharmacology
  • Animals
  • Antigens / administration & dosage
  • Antigens / pharmacology
  • Cellulose / chemistry*
  • Cellulose / pharmacology
  • Delayed-Action Preparations / chemistry*
  • Delayed-Action Preparations / pharmacology
  • Female
  • Immunity, Cellular / drug effects
  • Mice
  • Mice, Inbred C57BL
  • RAW 264.7 Cells
  • Tissue Scaffolds / chemistry*
  • Vaccination / methods
  • Vaccines / administration & dosage*
  • Vaccines / pharmacology

Substances

  • Adjuvants, Immunologic
  • Antigens
  • Delayed-Action Preparations
  • Vaccines
  • Cellulose